AMPERSAND CAPITAL PARTNERS
[Ampersand](http://www.ampersandventures.com/) is a middle market private equity firm focused on investments in two core sectors: Healthcare and Industrial.
AMPERSAND CAPITAL PARTNERS
Industry:
Angel Investment Finance Financial Services Health Care Venture Capital
Founded:
1988-01-01
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt WordPress Content Delivery Network Google Universal Analytics
Similar Organizations
Champlain Capital Partners LP.
A small and middle-market private equity fund focused on niche businesses in manufacturing
Correlation Ventures
Correlation Ventures finances early, seed, and later stage venture, and debt financing investments and is based in California.
Kapor Capital
Kapor Capital is an investment firm that invests in early-stage tech-enabled startups.
PCI Technologies
PCI Technologies is a private equity firm that focuses on merger, asset acquisition and stock exchange services for health care industries.
Current Advisors List
Advisor
1985-01-01
Advisor
Board_member
2015-09-01
Advisor
2011-09-01
Current Employees Featured
Stuart Auerbach Senior Advisor @ Ampersand Capital Partners
Senior Advisor
1991-01-01
David Q. Anderson Partner @ Ampersand Capital Partners
Partner
Patrick Walsh Operating Partner @ Ampersand Capital Partners
Operating Partner
2018-03-01
Laurence McCarthy Venture Partner @ Ampersand Capital Partners
Venture Partner
Julie F. Giles Senior Accountant @ Ampersand Capital Partners
Senior Accountant
2003-01-01
Trevor L. Wahlbrink Associate @ Ampersand Capital Partners
Associate
David J. Parker General Partner @ Ampersand Capital Partners
General Partner
Richard A. Charpie Founder and Managing Partner @ Ampersand Capital Partners
Founder and Managing Partner
Todd Johnson Operating Partner @ Ampersand Capital Partners
Operating Partner
Loretta M. McClary Tax counsel @ Ampersand Capital Partners
Tax counsel
1998-01-01
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2022-08-30 | Luina Bio | Luina Bio acquired by Ampersand Capital Partners | N/A |
| 2022-08-25 | Phosphorex | Phosphorex acquired by Ampersand Capital Partners | N/A |
| 2021-01-05 | Genezen Laboratories | Genezen Laboratories acquired by Ampersand Capital Partners | N/A |
| 2020-09-21 | GeneWerk | GeneWerk acquired by Ampersand Capital Partners | N/A |
| 2020-09-21 | ALPCO Diagnostics | ALPCO Diagnostics acquired by Ampersand Capital Partners | N/A |
| 2019-05-29 | Vibalogics | Vibalogics acquired by Ampersand Capital Partners | N/A |
| 2018-11-19 | Pacific Biomarkers | Pacific Biomarkers acquired by Ampersand Capital Partners | N/A |
| 2018-09-04 | NEOMED-LABS | NEOMED-LABS acquired by Ampersand Capital Partners | N/A |
| 2015-06-18 | Gyros Protein Technologies | Gyros Protein Technologies acquired by Ampersand Capital Partners | N/A |
| 2005-09-20 | RadPharm | RadPharm acquired by Ampersand Capital Partners | N/A |
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-06-23 | Sterling Medical Devices | Ampersand Capital Partners investment in Private Equity Round - Sterling Medical Devices | N/A |
| 2022-06-07 | AnaBios | Ampersand Capital Partners investment in Private Equity Round - AnaBios | 6.5 M USD |
| 2022-06-02 | Vernal Biosciences | Ampersand Capital Partners investment in Venture Round - Vernal Biosciences | 21 M USD |
| 2022-04-18 | Syft Technologies | Ampersand Capital Partners investment in Private Equity Round - Syft Technologies | N/A |
| 2022-03-01 | BioEcho Life Sciences | Ampersand Capital Partners investment in Private Equity Round - BioEcho Life Sciences | N/A |
| 2021-03-18 | Magritek Ltd | Ampersand Capital Partners investment in Private Equity Round - Magritek Ltd | N/A |
| 2021-03-08 | Arranta Bio | Ampersand Capital Partners investment in Series B - Arranta Bio | N/A |
| 2021-01-01 | Avista Pharma | Ampersand Capital Partners investment in Private Equity Round - Avista Pharma | N/A |
| 2021-01-01 | Brammer Bio | Ampersand Capital Partners investment in Private Equity Round - Brammer Bio | N/A |
| 2019-10-30 | Arranta Bio | Ampersand Capital Partners investment in Venture Round - Arranta Bio | 82 M USD |